Aclaris Therapeutics to Participate in Two September Healthcare Conferences
Aclaris Therapeutics (NASDAQ: ACRS), a clinical-stage biopharmaceutical company specializing in immuno-inflammatory diseases, has announced its participation in two major healthcare conferences in September 2025.
CEO Dr. Neal Walker and the senior leadership team will participate in a fireside chat at the Cantor Global Healthcare Conference on September 3 at 1:00 PM EDT. Additionally, Dr. Walker will deliver a corporate presentation at the H.C. Wainwright 27th Annual Global Investment Conference on September 9 at 9:00 AM EDT. Both events will be webcast live and archived on the company's website.
Aclaris Therapeutics (NASDAQ: ACRS), una società biofarmaceutica in fase clinica specializzata nelle malattie immuno-infiammatorie, ha annunciato la sua partecipazione a due importanti conferenze del settore sanitario a settembre 2025.
Il CEO, Dr. Neal Walker, insieme al team di dirigenti senior, prenderà parte a una fireside chat al Cantor Global Healthcare Conference il 3 settembre alle 13:00 EDT. Inoltre, il Dr. Walker terrà una presentazione aziendale al H.C. Wainwright 27th Annual Global Investment Conference il 9 settembre alle 9:00 EDT. Entrambi gli eventi saranno trasmessi in streaming e resteranno archiviati sul sito web della società.
Aclaris Therapeutics (NASDAQ: ACRS), una empresa biofarmacéutica en fase clínica especializada en enfermedades inmuno-inflamatorias, ha anunciado su participación en dos importantes conferencias sanitarias en septiembre de 2025.
El CEO, Dr. Neal Walker, y el equipo directivo senior participarán en una charla informal en el Cantor Global Healthcare Conference el 3 de septiembre a la 1:00 PM EDT. Además, el Dr. Walker ofrecerá una presentación corporativa en el H.C. Wainwright 27th Annual Global Investment Conference el 9 de septiembre a las 9:00 AM EDT. Ambos eventos se emitirán en directo y quedarán archivados en la web de la compañía.
Aclaris Therapeutics (NASDAQ: ACRS), 면역·염증성 질환을 전문으로 하는 임상 단계 바이오제약 회사가 2025년 9월에 열리는 주요 헬스케어 콘퍼런스 두 곳에 참가한다고 발표했습니다.
CEO 닐 워커(Dr. Neal Walker)와 고위 경영진은 Cantor Global Healthcare Conference에서 9월 3일 오후 1:00(EDT)에 파이어사이드 채팅에 참여합니다. 또한 워커 박사는 H.C. Wainwright 27th Annual Global Investment Conference에서 9월 9일 오전 9:00(EDT)에 기업 발표를 할 예정입니다. 두 행사는 모두 웹캐스트로 생중계되며 회사 웹사이트에 아카이브됩니다.
Aclaris Therapeutics (NASDAQ: ACRS), une société biopharmaceutique en phase clinique spécialisée dans les maladies immuno-inflammatoires, a annoncé sa participation à deux grandes conférences de santé en septembre 2025.
Le PDG, Dr Neal Walker, et l'équipe de direction participeront à une discussion informelle au Cantor Global Healthcare Conference le 3 septembre à 13h00 EDT. Par ailleurs, le Dr Walker présentera une communication d'entreprise au H.C. Wainwright 27th Annual Global Investment Conference le 9 septembre à 9h00 EDT. Les deux événements seront diffusés en direct par webcast et archivés sur le site web de la société.
Aclaris Therapeutics (NASDAQ: ACRS), ein biopharmazeutisches Unternehmen in klinischer Phase, das auf immun-entzündliche Erkrankungen spezialisiert ist, hat seine Teilnahme an zwei bedeutenden Gesundheitskonferenzen im September 2025 angekündigt.
CEO Dr. Neal Walker und das Führungsteam werden am Cantor Global Healthcare Conference am 3. September um 13:00 Uhr EDT an einem Fireside-Chat teilnehmen. Zusätzlich wird Dr. Walker am H.C. Wainwright 27th Annual Global Investment Conference am 9. September um 9:00 Uhr EDT eine Unternehmenspräsentation halten. Beide Veranstaltungen werden per Webcast live übertragen und auf der Unternehmenswebsite archiviert.
- None.
- None.
WAYNE, Pa., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferences in September.
- On Wednesday September 3, 2025, at 1:00 PM EDT, Aclaris’ Chief Executive Officer Dr. Neal Walker and other members of Aclaris’ senior leadership team will participate in a fireside chat during the Cantor Global Healthcare Conference in New York, NY.
- On Tuesday September 9, 2025, at 9:00 AM EDT, Dr. Walker will provide a corporate presentation during the H.C. Wainwright 27th Annual Global Investment Conference in New York, NY.
Live and archived webcasts of both events will be accessible on the Events page of https://www.aclaristx.com/. The webcasts will be available on the Aclaris website for at least 30 days.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&D engine. For additional information, please visit www.aclaristx.com and follow Aclaris on X (formerly Twitter) at @AclarisTx and on LinkedIn.
Aclaris Therapeutics Contact:
Will Roberts
Senior Vice President
Corporate Communications and Investor Relations
(484) 329-2125
wroberts@aclaristx.com
FAQ
When is Aclaris Therapeutics (ACRS) presenting at the Cantor Global Healthcare Conference 2025?
What time is Aclaris Therapeutics' presentation at the H.C. Wainwright Conference?
Where can I watch Aclaris Therapeutics' (ACRS) conference presentations?
Who will be presenting for Aclaris Therapeutics at these healthcare conferences?
